Pharmapedia Pro
Medicines/Generics/Co-Dergocrine Mesylate

Co-Dergocrine Mesylate

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Co-Dergocrine Mesylate is used to treat symptoms of mild to moderate dementia in elderly. In some countries , it has been used in the treatment of hypertension, migrain, and in peripheral vascular disease.
Indications
Co-Dergocrine Mesylate is primarily indicated in conditions like Cerebral insufficiency, Dementia, Dizziness, Headache, Impaired memory, Migraine, Vascular headaches.
Contraindications
Co-Dergocrine Mesylate is contraindicated in conditions like Hypersensitivity.
Side Effects
The symptomatic adverse reactions produced by Co-Dergocrine Mesylate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, GI upset, Nasal stiffness.
Warnings
Co-Dergocrine Mesylate should be used with caution in patients with severe bradycardia. Blood pressure should be checked following parentral administration as a drop in blood pressure may occur. It is classified as pregnancy category C and should be used during prgnancy only if clearly needed.
High Risk Groups
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
0.3 mg (0.3 (0.3)) 12 hourly IM — For one week. Followed by oral therapy 1.5 to 2 mg (1.8 (1.75)) 8 hourly PO — For atleast 3 months (For Once a day dosage 4.5mg before breakfast)
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Co-Dergocrine Mesylate was found.
Storage
Tab Protect from Sunlight.

Available Brands in Pakistan

1 active brand listed alphabetically.

CEREGIN

Active

PLATINUM PHARMACEUTICALS (PVT.) LTD.

DML: CEREGIN

Tabs

3 additional records are present but flagged "Unverified / Legacy" and not listed.